Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
3,337
-2,804
-46% -$187K 0.1% 123
2026
Q1
$386K Sell
6,141
-1,615
-21% -$112K 0.19% 85
2025
Q4
$515K Sell
7,756
-2,423
-24% -$157K 0.26% 65
2025
Q3
$685K Sell
10,179
-1,302
-11% -$103K 0.37% 58
2025
Q2
$1M Sell
11,481
-9,589
-46% -$752K 0.58% 41
2025
Q1
$1.44M Buy
21,070
+707
+3% +$57.7K 0.85% 26
2024
Q4
$1.58M Buy
20,363
+1,376
+7% +$102K 0.89% 26
2024
Q3
$1.27M Buy
18,987
+8,326
+78% +$684K 0.72% 30
2024
Q2
$1.21M Buy
10,661
+1,123
+12% +$142K 0.7% 32
2024
Q1
$1.32M Sell
9,538
-124
-1% -$15.6K 0.82% 28
2023
Q4
$1.2M Buy
+9,662
New +$987K 0.83% 26

Other funds holding DXCM

MN Wealth Advisors's DXCM Position: Q2 2026 in Review

MN Wealth Advisors reduced its DexCom (DXCM) stake by 46% in Q2 2026, selling an estimated $187K and leaving 3,337 shares worth $225K. The position accounts for 0.1% of the portfolio, ranked #123.

MN Wealth Advisors first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.58M in Q4 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MN Wealth Advisors held 3,337 shares of DexCom worth $225K as of Q2 2026.
  • MN Wealth Advisors sold 2,804 DexCom shares in Q2 2026, an estimated $187K.
  • DexCom made up 0.1% of MN Wealth Advisors's portfolio in Q2 2026, its #123 holding.
  • MN Wealth Advisors first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • MN Wealth Advisors's DexCom position peaked at $1.58M in Q4 2024.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MN Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.